中药猫爪草的研究概况与展望  

The Study Survey and Expectation of Chinese Drug Radix Ranunculi Ternati

作　　者：王爱武[1,2] 田景奎[1] 袁久荣[3] 吴丽敏[1] 

机构地区：[1]山东省立医院 [2]山东中医药大学,山东济南250014 [3]山东中医药大学

出　　处：《中国药业》2005年第1期25-27,共3页China Pharmaceuticals

摘　　要：目的:介绍猫爪草的研究概况,展望其开发前景。方法:采用文献追踪法对猫爪草的资源分布、商品质量检测、化学成分与药理作用、临床应用等方面进行介绍。结果与结论:猫爪草资源分布广泛,疗效确切,但质量检测有待规范,抗肿瘤、抗结核等的有效部位或成分值得深入研究,可望从中开发出抗肿瘤、抗耐药性结核杆菌的新型药物。Objective:To summarize the study survey and expect the foreground of Radix Ranunculi Ternati.Methods:The resourse distributions,product quality examinations,chemical constituents,pharmacological activities and clinical applications were reviewed by tracing literatures in this paper.Results and Conclusion:The resourse is abroad,curative effect is true,but the quality criterion will to be established,the effective components in antiumor and tuberculostatics deserve to be deeply researched.The new antiumor and tuberculostatics drugs will to be promisingly developed from Radix Ranunculi Ternati.

关 键 词：猫爪草 抗肿瘤 抗耐药性结核杆菌 

分 类 号：R282.71[医药卫生—中药学]